Idexx Laboratories (IDXX)
462.08 +2.22 (+0.48%) 11:21 ET [NASDAQ]
460.11 x 100 461.90 x 4
Realtime by (Cboe BZX)
460.11 x 100 461.90 x 4
Realtime 463.58 +3.72 (+0.81%) 08:00 ET
for Wed, Feb 26th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 3,897,504 | 3,660,953 | 3,367,324 | 3,215,360 | 2,706,655 |
Cost of Goods | 1,518,577 | 1,470,983 | 1,362,986 | 1,325,928 | 1,135,615 |
Gross Profit | 2,378,927 | 2,189,970 | 2,004,338 | 1,889,432 | 1,571,040 |
Operating Expenses | 1,251,167 | 1,093,825 | 1,106,559 | 958,332 | 877,131 |
Operating Income | 1,128,337 | 1,097,128 | 898,765 | 932,028 | 694,524 |
Interest Expense | 31,205 | 41,581 | 39,858 | 29,808 | 33,125 |
Other Income | 12,699 | 5,629 | 1,065 | 434 | 586 |
Pre-tax Income | 1,109,831 | 1,061,176 | 859,972 | 902,654 | 661,985 |
Income Tax | 221,964 | 216,134 | 180,883 | 157,810 | 79,854 |
Net Income Continuous | 887,867 | 845,042 | 679,089 | 744,844 | 582,131 |
Minority Interests | N/A | N/A | N/A | -1 | 355 |
Net Income | $887,867 | $845,042 | $679,089 | $744,845 | $581,776 |
EPS Basic Total Ops | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 |
EPS Basic Continuous Ops | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 |
EPS Diluted Total Ops | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 |
EPS Diluted Continuous Ops | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 |
EPS Diluted Before Non-Recurring Items | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 |
EBITDA(a) | $1,258,273 | $1,212,036 | $1,010,665 | $1,036,624 | $790,522 |